Comparison of the effect of anti-muscarinic agents on bladder activity, urinary ATP level, and autonomic nervous system in rats

Biomedical Research

Volumn 30, Issue 2, 2009, Pages 107-112

  Nishijima, Saori ^a   Sugaya, Kimio ^a   Kadekawa, Katsumi ^a   Naka, Hidekatsu ^a   Miyazato, Minoru ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; IMIDAFENACIN; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; TOLTERODINE; DOPAMINE; NORADRENALIN;

ADENOSINE TRIPHOSPHATE URINE LEVEL; ADRENALIN BLOOD LEVEL; ANTICHOLINERGIC EFFECT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLADDER CONTRACTION; BLADDER FUNCTION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CYSTOMETRY; FEMALE; HEART RATE; MORNING DOSAGE; NONHUMAN; NORADRENALIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT; URINE LEVEL; ANIMAL; BLADDER; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; TIME; URINE; UROTHELIUM;

RATTUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DOPAMINE; FEMALE; HEART RATE; MUSCARINIC ANTAGONISTS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; URINARY BLADDER; UROTHELIUM;

EID: 67649804913     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.30.107     Document Type: Article

References (19)

1. Abrams P and Andersson KE (2007) Muscarinic receptor antagonists for overactive bladder. BJU Int 100, 987-1006.
2. Andersson KE, Appell. F, Cardozo LD, Chapple C, Drutz HP, Finkbeiner AE, Haab F and Vela Navarrete R (1999) The pharmacological treatment of urinary incontinence. BJU Int 84, 923-947.
3. Andersson KE and Yoshida M (2003) Antimuscarinics and the overactive detrusor-which is the main mechanism of action? Eur Urol 43, 1-5.
4. Birder LA, Apodaca G, de Groat WC and Kanai AJ (1998) Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol Renal Physiol 275, F226-F229.
5. Birder LA, Barrick SR, Roppolo JR, Kanai AJ, de Groat WC, Kiss S and Buffington CA (2003) Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 285, F423-F429.
6. Birder LA and de Groat WC (2007) Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol 4, 46-54.
7. Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W and Lips KS (2007) Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80, 2303-2307.
8. Chess-Williams R (2002) Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 22, 133-145.
9. de Groat WC (2006) Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 147, S25-40.
10. Finney SM, Andersson KE, Gillespie JI and Stewart LH (2006) Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 98, 503-507.
11. Gabella G and Davis C (1998) Distribution of afferent axons in the bladder of rats. J Neurocytol 27, 141-155.
12. Homma Y, Yamaguchi T and Yamaguchi O (2008) A randomized, double-blind, placebo-controlled phase 11 dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder. Int J Urol 15, 809-815.
13. Kanai A, Roppolo J, Ikeda Y, Zabbarova I, Tai C, Birder L, Griffiths D, de Groat W and Fry C (2007) Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists. Am J Physiol Renal Physiol 292, F1065-F1072.
14. Kullmann FA, Artim DE, Birder LA and de Groat WC (2008) Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci 28, 1977-1987.
15. 2+ responses in cultured urothelial cells from rat. Am J Physiol Renal Physiol 294, F971-F981.
16. Madersbacher H and Murtz G (2001) Efficacy, tolerability and safety profile of propiverine in the treatment of the over-active bladder (non-neurogenic and neurogenic). World J Urol 19, 324-935.
17. 2+ sources. J Pharmacol Exp Ther 308, 47-53.
18. Tonini M, Rizzi CA, Perucca E, De Ponti F, D'Angelo L, Del Vecchio A and Crema A (1987) Depressant action of oxybutynin on the contractility of intestinal and urinary tract smooth muscle. J Pharm Pharmacol 39, 103-107.
19. Yoshida M, Miyamae Y, Iwashita H, Otani M and Inadome A (2004) Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63, 17-23.